Aicar (5-Aminoimidazole-4-carboxamide）
Cas No: 2627-69-2
MF:C9H14N4O5
MW: 258.23
Assay:98%
Appearance: white powder
Applications:
Aicar (AICA-Riboside) strongly inhibits the transcription of PPAR&alpha and the coactivation of PPAR&alpha. In adipocyte studies it has been shown to antagonize lipolysis induced by isoprenaline and has been suggested for use in kinase cascade research. Additionally, research indicates that AICAR blocks the differentiation of 3T3-L1 (sc-2243) adipocytes.
AICAR has been used clinically to treat and protect against cardiac ischemic injury.
Specifications: COA
|
Tests |
Specifications |
Results |
|
Appearance |
White powder |
Off-White powder |
|
HNMR |
Conforms to structure |
conforms |
|
LCMS |
Conforms to MW |
conforms |
|
Assay |
≧98.0% |
99.3% |
|
Conclusion |
Complies with enterprise standard |
|
USD
GBP